Recently, a study published in the Journal of the National Cancer Institute found that circulating vitamin D concentrations in the body are directly related to the risk of colorectal cancer. This study confirms Vitamin D was found to be a protective effect against colon cancer. In order to effectively prevent colorectal cancer, the optimal concentration of vitamin D used may be changed to the current recommendations of the National Academy of Medical Sciences.
Omega 3 fatty acids can aid in reducing the risk of heart attacks, especially among African Americans, while vitamin D can reduce cancer deaths over time. These are among the long-awaited findings of the Vitamin D and OmegA-3 TriaL (VITAL) study. VITAL is the first randomized clinical trial of a general population large enough to adequately address questions surrounding the effects of vitamin D and omega 3 fatty acids derived from fish oil, in high doses, on the risk of diseases such as heart attack, stroke and cancer.
The team found that omega 3 fish oil reduced heart attack rates but did not affect the risk of stroke or cancer. In addition, vitamin D did not significantly affect heart attack, stroke or cancer incidence but was associated with a decrease in cancer deaths that started one to two years after participants had begun treatment.
In addition to cardiovascular disease and cancer outcomes, VITAL will report on the effects of vitamin D and omega 3s on rates of diabetes, cognitive function, autoimmune disease, respiratory infections, depression and more in the months ahead.
Maxusn Industries is a American company founded Chino, CA in February 2002 with a strong international focus. Our products are sold in more than 25 countries over the five continents to nutrition and food, pharmaceutical, cosmetic and feed sector. Additionally our product ranges includes: amino acid , vitamin series, herb extract and fruit powder.